Navigation Links
Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive
Date:12/1/2008

WARSAW, Ind., Dec. 1 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today that Jeffery A. McCaulley has joined the Company as President, Zimmer Reconstructive. He will have responsibility for the Company's activities in the reconstructive devices market, including Global Marketing and Americas Sales. Mr. McCaulley will report to David Dvorak, Zimmer Holdings President and Chief Executive Officer.

"Jeff has a tremendous background from a variety of health care settings and has established an outstanding record for building businesses," said Mr. Dvorak. "The Reconstructive category represents the great majority of our annual revenues and the market is expected to remain a growth opportunity given the aging of the population and other societal factors. We are excited to have Jeff apply his skills and experiences to our effort to build momentum and long-term leadership in reconstructive devices."

Mr. McCaulley most recently served as President and Chief Executive Officer of the Health Division of Wolters Kluwer, the leading provider of scientific information and workflow solutions for healthcare professionals, providers, payors and the pharmaceutical industry. Prior to joining Wolters Kluwer in 2004, he served three years as Vice President and General Manager of the Diabetes Division of Medtronic, Inc. He began his medical devices career in 1989 with General Electric Medical Systems, where he held positions of increasing responsibility in sales, marketing and general management, last serving as President and CEO of GE Clinical Services.

A graduate of the University of Cincinnati with a Bachelor of Science in Aerospace Engineering, Mr. McCaulley also holds an MBA from the Owen Graduate School of Management at Vanderbilt University.

"I'm looking forward to being a part of the Zimmer team and building on the Company's historic strengths in the reconstructive market," said Mr. McCaulley. "I regard this as an excellent opportunity to help Zimmer reassert itself and build for sustainable growth. Zimmer has tremendous assets -- great people, a legendary sales force and advanced technologies -- that can be leveraged for real competitive advantage."

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.

For more information about Zimmer, visit www.zimmer.com

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Zimmer Holdings to Present at Credit Suisse 2008 Healthcare Conference
2. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
3. Zimmermans Latest Win Has Everyone Smiling
4. Zimmer Holdings to Present at Thomas Weisel Partners Conference
5. Zimmer Holdings Issues Clarification Regarding NexGen Knee System
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2008 Results
7. Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program
8. Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses
9. Zimmer Holdings to Present at Deutsche Bank 33rd Annual Health Care Conference
10. Zimmer Holdings, Inc. Reports First Quarter Financial Results
11. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology: